Intravitreal anti-VEGF agents and cardiovascular risk
نویسندگان
چکیده
منابع مشابه
The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model
PURPOSE To investigate the effect of intravitreal pegaptanib, bevacizumab, and ranibizumab on blood-vessel formation during cutaneous wound healing in a rabbit model and to compare this effect to placebo controls. METHODS Forty New Zealand albino rabbits underwent full thickness cutaneous wounds using 6-mm dermatologic punch biopsies. The rabbits were assigned to four groups of ten, each rece...
متن کاملAnti-VEGF Agents and Glaucoma Filtering Surgery
Despite the introduction of various modern and minimally invasive glaucoma procedures, trabeculectomy is still considered to be the most effective treatment for glaucoma and the cornerstone of management for this potentially blinding condition. 1 It is a rather unique surgical procedure in medicine, because prevention of wound healing is crucial for surgical success. 2 Indeed, progressive fibro...
متن کاملGlobal reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis
PURPOSE To report on endophthalmitis occurrence and associated risk factors following the intravitreal injection of anti-VEGF agents based on a review of published literature. MATERIALS AND METHODS A Medline search was performed using the terms "bevacizumab" and "ranibizumab". A total of 534 English-language articles of varying design and published from 2006 to November 2013 were analyzed for...
متن کاملIntravitreal anti-VEGF therapy for neovascular age-related macular degeneration and the risk of stroke.
The purpose of this study was to compare the vascular event rate in AMD patients treated with an intravitreal VEGF inhibitor with a historical control group treated with photodynamic therapy. We reviewed medical records of 83 patients treated with intravitreal anti-VEGF for AMD between 2005-2007, and 60 patients treated with PDT between 2001-2004. Mean follow-up in the anti-VEGF group was 40 mo...
متن کاملVitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
Vascular endothelial growth factor (VEGF) is a potent promoter of angiogenesis involved in a wide variety of physiologic processes. Intravitreal injections targeting VEGF have transformed the treatment of neovascular retinal diseases. Currently, there are four anti-VEGF agents in use: bevacizumab, ranibizumab, pegaptanib, and aflibercept. The success and frequency of anti-VEGF therapy have made...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Internal and Emergency Medicine
سال: 2019
ISSN: 1828-0447,1970-9366
DOI: 10.1007/s11739-019-02253-7